Danaher Corporation

Danaher Corporation is a global science and technology innovator dedicated to advancing human health. Headquartered in Washington, D.C., United States, the company's core mission involves providing essential products, services, and platforms that drive scientific advancement and critical analysis within the healthcare sector.

The company operates through three primary business segments: Biotechnology, Life Sciences, and Diagnostics. Across these segments, Danaher offers a comprehensive portfolio including analytical instruments, laboratory equipment, reagents, consumables, and software. These products and services are vital for research, manufacturing, and diagnostic processes, catering to a broad customer base that includes biopharmaceutical companies, academic institutions, clinical laboratories, and hospitals.

Rainer Blair has served as the President and Chief Executive Officer of Danaher Corporation since September 2020. The company is recognized for its Danaher Business System (DBS), an operational framework that emphasizes continuous improvement and lean principles. In a significant recent development, Danaher completed the acquisition of Masimo Corporation in June 2026, integrating Masimo's specialty diagnostics and patient monitoring solutions into its diagnostics portfolio.